Innovation and Product Development news

• 

  4 May 2026

  Stahl launches Repura barrier coatings for paper packaging

  Repura™ coatings deliver high oil, water/MVTR and oxygen barriers for paper & board and flexible packaging; repulpable, food-contact capable, customizable—shown at Interpack 2026
• 

  4 May 2026

  Siemens expands digital portfolio for water & waste management

  Real-time water-quality monitoring, SIWA Treatment Optimizer (digital twin) cutting energy/emissions up to 25%, soft sensors, integrated control center and expanded waste-management automation
• 

  4 May 2026

  UPM and BASF advance recyclable fiber-based packaging

  Barrier papers paired with Joncryl HPB coatings enable high-performance, recyclable fiber-based packaging; samples to be shown at interpack 2026, supporting design-for-recycling rules.
• 

  1 May 2026

  Petrobras starts Búzios 8 (P-79) production

  Brought online three months early, FPSO adds 180,000 bpd and 7.2M m³/d compression, raising field capacity to ~1.33M bpd; 14 wells planned and up to 3M m³/d gas export.
• 

  1 May 2026

  Novo Nordisk launches Ozempic pill — FDA‑approved oral semaglutide for adults with type 2 diabetes

  Tablets (1.5, 4, 9 mg) debut in US May 4. Reformulated from Rybelsus, available at 70,000+ pharmacies; insurance from $25; self-pay $149/199/299/month. Approved to reduce cardiovascular events
• 

  30 April 2026

  Sinopec launches Fenghuo industrial AI agent

  Introduces 'Fenghuo' industrial AI agent: a production-capable digital colleague that analyzes data, runs engineering simulations, invokes toolchains, and executes long multi-step tasks autonomously.

• 

  30 April 2026

  Evonik expands Americas fast‑cure epoxy range with Ancamine 2868 and 2844

  New epoxy hardeners enable rapid thin-film cure and fast property build at low temps/high humidity, boosting formulation flexibility and corrosion/carbamation resistance for protective coatings
• 

  30 April 2026

  Petrobras posts 1Q26 own production record of 3.23 MMboed

  Ramp-up of multiple FPSOs and 10 new wells drove production gains (3.7% QoQ, 16.1% YoY); operated production 4.65 MMboed. Refining utilization, S10 diesel output and logistics records; LPG imports fell.
• 

  30 April 2026

  Symrise expands Food & Beverage capabilities in Barcelona

  Upgraded site adds powdered production and large-scale mixer, modern application and quality labs for faster prototyping, smoother scale-up, local technical support, and solar/water reuse.
• 

  30 April 2026

  Umicore Q1 momentum points to ~€1bn adjusted EBITDA in 2026

  Strong Q1: Catalysis and Recycling strong; Specialty led by cobalt; CAM volumes modest, take‑or‑pay compensation; anode JV in place; capex up; leverage <2x
• 

  30 April 2026

  Borouge Q1 2026: $156M Net Profit on Operational Resilience

  Q1 revenue $1.2B; production 1.21Mt (98% capacity), sales 1.09Mt. 61% of March output rerouted via alternative logistics. Prices rose 62% in March. H2 2025 dividend $658M; merger forms global polyolefins platform.
• 

  30 April 2026

  Roche to present ophthalmology portfolio data at ARVO 2026

  ARVO 2026: real‑world data show Vabysmo reduces retinal fluid in nAMD/DME; Susvimo enables sustained delivery with lower treatment burden; early vamikibart IL‑6 results; 45+ abstracts.
• 

  30 April 2026

  Eli Lilly Q1 2026: Revenue up 56%, raises full‑year guidance

  EPS jumped ~170% reported (~156% non‑GAAP); volume growth offset lower realized prices; FDA approved oral GLP‑1 Foundayo; positive Phase‑3 readouts; four acquisitions announced
• 

  30 April 2026

  Merck & Co Q1 2026 Results — Sales Growth, Regulatory Approvals and Clinical Milestones

  Q1 revenue $16.3B; KEYTRUDA $8.0B. GAAP loss $1.72/sh, non-GAAP loss $1.28/sh after $9.0B Cidara charge. Announced Terns acquisition; raised 2026 sales to $65.8-67.0B and non-GAAP EPS $5.04-5.16
• 

  29 April 2026

  Genentech to present ophthalmology data at ARVO 2026

  ARVO presentations: real-world Vabysmo data show retinal drying in wet AMD/DME; Susvimo demonstrates sustained delivery and reduced treatment burden; vamikibart shows early efficacy; >45 abstracts
• 

  29 April 2026

  Novo Nordisk: Denecimig (Mim8) reduces annualised bleeding rate in haemophilia A regardless of inhibitor status

  Denecimig (Mim8) cut annualised bleeding rates in haemophilia A (with/without inhibitors) in Phase 3 FRONTIER2 for once-monthly/weekly dosing; well tolerated, no thromboembolic events
• 

  29 April 2026

  Evonik opens PEEK magnet‑wire lab in China

  China lab develops PEEK rectangular magnet-wire for NEV motors: extrusion/coating, dimensional checks and reliability tests (BDV, PDIV, corona, oil-aging) to accelerate product development.
• 

  29 April 2026

  GSK Q1 2026 — Specialty Medicines Drive Growth

  Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
• 

  29 April 2026

  MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed

  Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
• 

  29 April 2026

  AkzoNobel adds Iris CMX drone for precise aircraft coating inspections

  Aerofleet adds a contact-sensor drone to pair with its visual-scan drone, capturing thickness, color and gloss. Dual-drone inspections take ~30 min, improving repaint timing and cutting costs.
• 

  29 April 2026

  BASF’s industrial Cathedral and the ground it stands on

  Integrated site captured synergies for decades—cutting costs, funding R&D—but gas-price shock in 2022 exposed systemic risk; response: restructure Ludwigshafen and expand production abroad.
• 

  29 April 2026

  UPM Q1 2026: Strong start led by decarbonization solutions

  Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
• 

  29 April 2026

  Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed

  Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
• 

  28 April 2026

  Plastic Ingenuity adopts PureCycle PureFive recycled PP for coffee lids

  Coffee lids now use 25-100% recycled polypropylene from a dissolution process; material retains virgin-like performance, has FDA food-contact clearance and GreenCircle certification.
• 

  28 April 2026

  GSK: FDA grants priority review and Breakthrough Therapy for bepirovirsen

  Phase III B-Well trials showed significantly higher functional cure rates and acceptable safety in chronic hepatitis B; drug is an antisense oligonucleotide; PDUFA date 26 Oct 2026
• 

  28 April 2026

  MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China

  Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.
• 

  28 April 2026

  Novo Nordisk to present Wegovy and next‑generation obesity data at ECO 2026

  Presenting 52 abstracts at ECO: data on semaglutide (injectable and oral), higher‑dose 7.2 mg, CagriSema combo, menopause effects, CV risk, weight‑loss timelines and real‑world outcomes.
• 

  28 April 2026

  Evonik opens Asia PAthletic Center for sports polyamide innovation

  Offers R&D, ISO/ASTM testing, pilot processing, 3D samples and application support for long‑chain polyamides (PEBAs) to accelerate sports and consumer product commercialization
• 

  28 April 2026

  BASF and Nutrien partner to expand farmer access to low‑carbon biofuel markets

  Farmers get agronomist support and digital tools to document low-carbon-intensity corn, connect with biorefineries, and access low-CI biofuel programs (e.g., Section 45Z).
• 

  28 April 2026

  Elkem wins NOK 87m from Enova to scale biocarbon use in silicon production

  Project (total NOK242m, 2026–28) will test industrial biocarbon across labs, pilots and five smelters to double biocarbon share (from ~25%) by 2030, potentially cutting up to 0.5 Mt CO2/yr